Epidemiology of NSAID-related gastroduodenal mucosal injury

Citation
C. Aalykke et K. Lauritsen, Epidemiology of NSAID-related gastroduodenal mucosal injury, BEST PR RES, 15(5), 2001, pp. 705-722
Citations number
91
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
ISSN journal
15216918 → ACNP
Volume
15
Issue
5
Year of publication
2001
Pages
705 - 722
Database
ISI
SICI code
1521-6918(200110)15:5<705:EONGMI>2.0.ZU;2-1
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the agents most fr equently used against musculoskeletal and rheumatic disorders throughout th e world. The gastroduodenal adverse effects include dyspepsia without endos copically proven damage, asymptomatic endoscopic lesions of submucosal haem orrhage, erosions and ulcers, and-most important-ulcer complications. Estab lished risk factors for NSAID-associated ulcer complications include patien t-specific factors such as advanced age, female gender, a history of peptic ulcer, and drug-specific factors such as the use of non-selective NSAIDs ( type, dose, duration, multiple use) and concomitant anticoagulant drugs or corticosteroids. Probable risk factors comprise Helicobacter pylori infecti on and heavy consumption of alcohol, whereas use of selective serotonin re- uptake inhibitors, smoking and a number of other factors have also been pro posed to contribute. Knowledge of absolute risk estimates is important for clinical decision making. The aim of this chapter is to summarize the epide miological data related to the broad spectrum of iatrogenic gastroduodenal mucosal injury.